BeOne Medicines Ownership | Who Owns BeOne Medicines?
BeOne Medicines Ownership Summary
BeOne Medicines is owned by 11.21% institutional investors, 17.30% insiders, and 71.49% retail investors. Capital investors is the largest institutional shareholder, holding 4.64% of ONC shares.
ONC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BeOne Medicines | 11.21% | 17.30% | 71.49% |
| Sector | Healthcare Stocks | 232.64% | 10.66% | -143.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Capital investors | 5.11M | 4.64% | $1.55B |
| Primecap management co/ca/ | 4.98M | 4.52% | $1.51B |
| Thomas j. herzfeld advisors | 2.05M | 1.86% | $29.00M |
| Capital, inc./ca/ | 307.66K | 0.28% | $93.47M |
| Baird financial group | 304.34K | 0.28% | $92.46M |
| Candriam s.c.a. | 197.26K | 0.18% | $59.93M |
| Nuveen | 194.12K | 0.18% | $58.98M |
| Bnp paribas arbitrage, snc | 193.95K | 0.18% | $58.92M |
| Capital sarl | 152.51K | 0.14% | $46.34M |
| Marshall wace, llp | 152.30K | 0.14% | $46.27B |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Thomas j. herzfeld advisors | 2.05M | 9.81% | $29.00M |
| Patient square capital lp | 69.31K | 4.51% | $21.06M |
| Nan fung group | 15.72K | 4.28% | $4.78M |
| Healthinvest partners ab | 40.43K | 3.92% | $12.28M |
| Tuttle capital management | 1.76K | 1.18% | $533.49K |
| Primecap management co/ca/ | 4.98M | 1.15% | $1.51B |
| Slow capital | 27.30K | 0.99% | $8.29M |
| North ground capital | 135.32K | 0.95% | $1.91M |
| Capital sarl | 152.51K | 0.74% | $46.34M |
| Capital, inc./ca/ | 307.66K | 0.74% | $93.47M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Thomas j. herzfeld advisors | 2.05M | 9.81% | 2.05M |
| North ground capital | 135.32K | 0.95% | 135.32K |
| Goldman sachs group | 148.71K | 0.01% | 104.48K |
| Arete wealth advisors | 99.33K | 0.09% | 99.33K |
| Bnp paribas arbitrage, snc | 193.95K | 0.03% | 97.24K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Marshall wace, llp | 152.30K | 0.04% | -160.14K |
| Nuveen | 194.12K | 0.02% | -112.39K |
| Primecap management co/ca/ | 4.98M | 1.15% | -99.88K |
| 1832 asset management | - | - | -80.00K |
| Jpmorgan chase | 7.45K | 0.00% | -41.37K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Thomas j. herzfeld advisors | 2.05M | 9.81% | 2.05M | $29.00M |
| North ground capital | 135.32K | 0.95% | 135.32K | $1.91M |
| Arete wealth advisors | 99.33K | 0.09% | 99.33K | $1.40M |
| Resources investment advisors, llc. | 97.13K | 0.01% | 97.13K | $1.37M |
| Morgan stanley | 79.47K | 0.00% | 79.47K | $1.12M |
Sold Out
| Holder | Change |
|---|---|
| Hm payson | -2.00 |
| Bessemer group | -6.00 |
| Td waterhouse canada | -9.00 |
| Wealthspire advisors | -20.00 |
| Alerus financial na | -21.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 154 | -44.80% | 12,358,898 | -62.55% | 11 | 1.25% | 87 | -43.87% | 40 | -48.72% |
| Sep 30, 2025 | 279 | 10.71% | 32,997,831 | -4.21% | 29 | 2.97% | 155 | 30.25% | 78 | -8.24% |
| Jun 30, 2025 | 252 | -8.70% | 34,449,266 | -19.00% | 31 | 2.01% | 119 | -21.71% | 85 | 8.97% |
| Mar 31, 2025 | 276 | 16.95% | 42,530,835 | -2.67% | 39 | 2.35% | 152 | 36.94% | 78 | -1.27% |
| Dec 31, 2024 | 236 | -1.67% | 43,698,179 | -6.24% | 41 | 2.08% | 111 | - | 79 | -8.14% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 11, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | $102.30K |
| Feb 04, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | $348.60K |
| Feb 04, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | $231.60K |
| Jan 07, 2026 | Lee Chan Henry | SVP, General Counsel | Sell | $220.29K |
| Dec 15, 2025 | OYLER JOHN | Chief Executive Officer | Sell | $1.93M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 4 |
| 2025 Q4 | - | 47 |
| 2025 Q3 | - | 42 |
| 2025 Q2 | - | 38 |
| 2025 Q1 | - | 2 |
ONC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools